OpenAI Academy
SIGN IN

Home

OpenAI Academy

Unlock the opportunities of the AI era by equipping yourself with the knowledge and skills to harness artificial intelligence effectively.
Expert & Community-Led Learning
Engage with OpenAI experts and external innovators to explore real-world AI applications and the latest industry trends.
Connections & Collaboration
Build meaningful relationships with peers, innovators, and industry leaders through discussions, shared learning, and community-driven projects.
Stay Ahead with AI
Learn about new products and the latest cutting-edge solutions directly from OpenAI experts—keeping you informed and ready to innovate.

Events

5:00 PM - 6:00 PM, Jan 15 GMT
Small Business Jam: Online Skill Lab
Learn More
7:00 PM - 8:00 PM, Dec 18 GMT
Prompting with Purpose: Best Practices and Techniques for ChatGPT
7:00 PM - 8:00 PM, Dec 15 GMT
ChatGPT Foundations: Getting Started with AI
6:00 PM - 7:00 PM, Dec 11 GMT
ChatGPT for Education 102

Content

Blog
Cell reprogramming for longer, healthier lives
Junevity is a new biotech co-founded by entrepreneur Rob Cahill, UCSF scientists Janine Sengstack and Hao Li, and veteran CEO John Hoekman, with a mission to reprogram aging cells using small interfering RNA (siRNA). Cahill’s path from software founder to bioinformatics and lab work was shaped by family experiences with aging and Parkinson’s, pushing him toward preventive, disease-modifying therapies. From day one, Junevity made AI part of its operating system: every employee gets ChatGPT, and OpenAI models augment the company’s genomics and machine-learning pipelines. The team estimates its first development candidate, a liver-targeted siRNA program for Type 2 diabetes and obesity, can reach key milestones at 2–6x lower cost and 2–3x faster timelines than typical industry norms.
Dec 19th, 2025 | Views 62
Blog
From decades without answers to a diagnosis in weeks
Probably Genetic funds free at-home genetic testing and counseling, pairing it with an AI-driven symptom intake that converts long, free-form narratives into structured phenotype data and candidate diagnoses. For Elizabeth “Betsy” Minium and her daughter Kali, that approach ended a 31-year search marked by inconclusive labels and dead ends, culminating in a Pitt-Hopkins syndrome diagnosis tied to loss of function in one copy of the TCF4 gene.
Dec 19th, 2025 | Views 32
Blog
A new playbook for drug repurposing
Immunologist Dr. Oral Alpan is using GPT-5 Pro to surface new uses for existing FDA-approved drugs by starting from real-world clinical vignettes and working backward to mechanism. A patient with severe eczema and Food Protein Induced Enterocolitis Syndrome (FPIES) stopped reacting to wheat after beginning dupilumab, then relapsed when coverage lapsed and improved again after restarting, prompting Amerimmune to document additional cases. To test whether AI could connect the dots before the observation became part of the literature, Alpan’s team provided GPT-5 Pro the de-identified case and received dupilumab as the top-ranked candidate, alongside mechanistic rationale and risk considerations. The same workflow is now being applied to other conditions where immune subtypes may be hiding in plain sight, helping prioritize repurposing candidates such as fevipiprant for prospective study in areas like IBS and POTS.
Dec 19th, 2025 | Views 22

About OpenAI Academy

People around the world are embracing generative AI to solve complex problems and enhance creativity, productivity, and learning. OpenAI Academy will help them harness AI’s transformative power through workshops, discussions, and digital content—ranging from foundational AI literacy to advanced integration for engineers. With a mix of online and in-person events, the Academy fosters a vibrant, collaborative community where participants of all backgrounds can gain actionable insights and drive innovation in their fields.
About OpenAI Academy
title
Events
Join virtual and in-person gatherings in your community to learn, network, and collaborate with peers and experts.
title
Knowledge Hub
Explore quick videos, tutorials, and resources—from AI basics to more advanced content.
title
Community Groups
Connect with peers by interest or location for discussions, shared learning, and collaboration.
title
Connect
Message fellow members to exchange ideas, build relationships, and grow your network.

Frequently Asked Questions

What is OpenAI’s mission?

OpenAI’s mission is to ensure artificial intelligence benefits all of humanity. We aim to create AI tools that empower people, solve hard problems, and drive progress across communities.

Why was OpenAI Academy created?

We launched OpenAI Academy to democratize access to AI knowledge. Our goal is to empower individuals from all backgrounds to confidently integrate AI into their lives, work, and communities.

Who can join OpenAI Academy?

OpenAI Academy is open to everyone, with free enrollment to ensure broad access. Some specialized community groups may require invitations or referrals.

Does OpenAI Academy offer certifications?

We’re going to expand the OpenAI Academy by offering certifications for different levels of AI fluency, from the basics of prompt engineering to AI-enabled work. We plan to pilot OpenAI Certifications starting in late 2025 / early 2026 and look forward to sharing more information soon.

In what languages is OpenAI Academy available?

Currently, OpenAI Academy programming is available in English, with plans to expand to additional languages soon.

Can I host an OpenAI Academy in my community?

We are always looking for motivated hosts across the country and around the world. Ideal hosts include academic institutions and community groups eager to help their members embrace and adopt AI. Contact us [email protected] to express your interest.

Where can I find out about local events?

Once you join OpenAI Academy, navigate to the Events section in the left-hand menu bar to explore upcoming virtual and in-person gatherings.

Where will local events take place?

OpenAI Academy is starting its programs in the United States and plans to scale globally soon.

Terms of Service
Privacy Policy
Code of Conduct